Literature DB >> 19360360

miR-145 inhibits breast cancer cell growth through RTKN.

Shihua Wang1, Chunjing Bian, Zhuo Yang, Ye Bo, Jing Li, Lifen Zeng, Hong Zhou, Robert Chunhua Zhao.   

Abstract

MicroRNAs (miRNAs) represent a class of small non-coding RNAs regulating gene expression by inducing RNA degradation or interfering with translation. Aberrant miRNA expression has been described for several human malignancies. Herein, we show that miR-145 is down-regulated in human cancer cell line MCF-7 when compared to normal human mammary epithelial cell line MCF10A. Overexpression of miR-145 by plasmid inhibits MCF-7 cell growth and induces apoptosis. Subsequently, RTKN is identified as a potential miR-145 target by bioinformatics. Using reporter constructs, we show that the RTKN 3' untranslated region (3'UTR) carries the directly binding site of miR-145. Additionally, overexpression of miR-145 in MCF-7 reduces RTKN protein expression as well as mRNA level. Furthermore, down-regulation of RTKN by siRNA can inhibit MCF-7 cell growth. Taken together, we propose that loss of miR-145 may provide a selective growth advantage for MCF-7 by targeting RTKN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19360360

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  64 in total

Review 1.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

2.  MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.

Authors:  Chao Zou; Qing Xu; Feng Mao; Dan Li; Chuanxiu Bian; Ling-Zhi Liu; Yue Jiang; Xiaona Chen; Yanting Qi; Xiaolong Zhang; Xuejing Wang; Qiang Sun; Hsiang-Fu Kung; Marie C Lin; Andreas Dress; Fiona Wardle; Bing-Hua Jiang; Lihui Lai
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

3.  The effect of recombinant lentiviral vector encoding miR-145 on human esophageal cancer cells.

Authors:  Tian-Yun Wang; Qing-Qing Zhang; Xi Zhang; Qiu-Li Sun; Chun-Peng Zhao; Xiao-Yin Wang
Journal:  Tumour Biol       Date:  2015-07-09

4.  lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6.

Authors:  Gabriel Eades; Benjamin Wolfson; Yongshu Zhang; Qinglin Li; Yuan Yao; Qun Zhou
Journal:  Mol Cancer Res       Date:  2014-09-24       Impact factor: 5.852

5.  MicroRNA-145 sensitizes cervical cancer cells to low-dose irradiation by downregulating OCT4 expression.

Authors:  Siqi Yan; Xiangjun Li; Qiao Jin; Jun Yuan
Journal:  Exp Ther Med       Date:  2016-09-20       Impact factor: 2.447

Review 6.  MiR-145: a potential biomarker of cancer migration and invasion.

Authors:  Wen-Xiu Xu; Zhen Liu; Fei Deng; Dan-Dan Wang; Xing-Wang Li; Tian Tian; Jian Zhang; Jin-Hai Tang
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

7.  Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer.

Authors:  Rui-Lei Liu; Ye Dong; Yan-Zhen Deng; Wen-Jun Wang; Wei-Dong Li
Journal:  Tumour Biol       Date:  2015-04-27

Review 8.  Microprocessor of microRNAs: regulation and potential for therapeutic intervention.

Authors:  Kevin J Beezhold; Vince Castranova; Fei Chen
Journal:  Mol Cancer       Date:  2010-06-01       Impact factor: 27.401

9.  miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.

Authors:  T Chiyomaru; H Enokida; S Tatarano; K Kawahara; Y Uchida; K Nishiyama; L Fujimura; N Kikkawa; N Seki; M Nakagawa
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

10.  miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w.

Authors:  Lei Shen; Jia Li; Liping Xu; Jie Ma; Hua Li; Xigang Xiao; Junyong Zhao; Lin Fang
Journal:  Exp Ther Med       Date:  2011-12-22       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.